Literature DB >> 27101817

Alarmins and Antitumor Immunity.

Yingjie Nie1, De Yang2, Joost J Oppenheim3.   

Abstract

PURPOSE: Alarmins are constitutively present endogenous molecules that essentially act as early warning signals for the immune system. We provide a brief overview of major alarmins and highlight their roles in tumor immunity.
METHODS: We searched PubMed up to January 10, 2016, using alarmins and/or damage-associated molecular patterns (DAMPs), as key words. We selected and reviewed articles that focused on the discovery and functions of alarmin and their roles in tumor immunity.
FINDINGS: Alarmins are essentially endogenous immunostimulatory DAMP molecules that are exposed in response to danger (eg, infection or tissue injury) as a result of degranulation, cell death, or induction. They are sensed by chemotactic receptors and pattern recognition receptors to induce immune responses by promoting the recruitment and activation of leukocytes, particularly antigen-presenting cells. IMPLICATIONS: Accumulating data suggest that certain alarmins, High-mobility group nucleosome-binding protein 1 (HMGN1) in particular, contribute to the generation of antitumor immunity. Some alarmins can also be used as cancer biomarkers. Therefore, alarmins can potentially be applied for our fight against cancers.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  alarmin; biomarker; damage-associated molecular patterns; immune response; pattern recognition receptor; tumor immunity

Mesh:

Substances:

Year:  2016        PMID: 27101817      PMCID: PMC6314656          DOI: 10.1016/j.clinthera.2016.03.021

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  17 in total

1.  Tranexamic acid suppresses the release of mitochondrial DNA, protects the endothelial monolayer and enhances oxidative phosphorylation.

Authors:  Igor Prudovsky; Damien Carter; Doreen Kacer; Monica Palmeri; Tee Soul; Chloe Kumpel; Kathleen Pyburn; Karyn Barrett; Victoria DeMambro; Ilya Alexandrov; Irina Brandina; Robert Kramer; Joseph Rappold
Journal:  J Cell Physiol       Date:  2019-04-02       Impact factor: 6.384

2.  The Future of the Cytokine Discipline.

Authors:  Joost J Oppenheim
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-09-04       Impact factor: 10.005

3.  Association Between Serum Alarmin Levels and Disease-specific Indices in Patients With Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis.

Authors:  Sung Soo Ahn; Taejun Yoon; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

4.  Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma.

Authors:  Angelo Della Corte; Claudio Sallemi; Francesca Ratti; Lorenzo Monfardini; Simone Gusmini; Federica Cipriani; Renato Pennella; Domenico Santangelo; Valentina Burgio; Andrea Casadei-Gardini; Luca Aldrighetti; Francesco De Cobelli
Journal:  Cardiovasc Intervent Radiol       Date:  2022-09-30       Impact factor: 2.797

5.  Investigation of the effects of overexpression of jumping translocation breakpoint (JTB) protein in MCF7 cells for potential use as a biomarker in breast cancer.

Authors:  Madhuri Jayathirtha; Anca-Narcisa Neagu; Danielle Whitham; Shelby Alwine; Costel C Darie
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

6.  Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines.

Authors:  Qian Li; Jiao Chen; Xiaoying Li; Bomiao Cui; Yaping Fan; Ning Geng; Qianming Chen; Ping Zhang; Yun Feng
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

Review 7.  Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment.

Authors:  Mansi Saxena; Nina Bhardwaj
Journal:  Trends Cancer       Date:  2018-02

8.  PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions.

Authors:  Giuseppe Ercolano; Alejandra Gomez-Cadena; Nina Dumauthioz; Giulia Vanoni; Mario Kreutzfeldt; Tania Wyss; Liliane Michalik; Romain Loyon; Angela Ianaro; Ping-Chih Ho; Christophe Borg; Manfred Kopf; Doron Merkler; Philippe Krebs; Pedro Romero; Sara Trabanelli; Camilla Jandus
Journal:  Nat Commun       Date:  2021-05-05       Impact factor: 14.919

Review 9.  The immune system in cancer metastasis: friend or foe?

Authors:  Louise M E Janssen; Emma E Ramsay; Craig D Logsdon; Willem W Overwijk
Journal:  J Immunother Cancer       Date:  2017-10-17       Impact factor: 13.751

Review 10.  The P2X7 Receptor-Interleukin-1 Liaison.

Authors:  Anna Lisa Giuliani; Alba C Sarti; Simonetta Falzoni; Francesco Di Virgilio
Journal:  Front Pharmacol       Date:  2017-03-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.